Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124092916 | 12409291 | 6 | F | 20160725 | 20160526 | 20160728 | EXP | JP-PFIZER INC-2016273889 | PFIZER | SHIMADA, K.. CUTANEOUS ASPERGILLOSIS IN A SEVERELY BURNED PATIENT. THE JOURNAL OF TOKYO MEDICAL UNIVERSITY. 2016;74 (1):85-93 | 30.00 | YR | M | Y | 0.00000 | 20160728 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124092916 | 12409291 | 1 | PS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 4.5 G, 4X/DAY | 50750 | 4.5 | G | INJECTION | QID | ||||||
| 124092916 | 12409291 | 2 | SS | Prodif | FOSFLUCONAZOLE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 124092916 | 12409291 | 3 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | 19949 | ||||||||||||
| 124092916 | 12409291 | 4 | SS | MEROPENEM. | MEROPENEM | 1 | UNK | U | 90940 | ||||||||||
| 124092916 | 12409291 | 5 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 124092916 | 12409291 | 6 | SS | CRAVIT | LEVOFLOXACIN | 1 | Intravenous drip | UNK | U | 0 | |||||||||
| 124092916 | 12409291 | 7 | SS | FUNGUARD | MICAFUNGIN SODIUM | 1 | Intravenous drip | UNK | 0 | ||||||||||
| 124092916 | 12409291 | 8 | C | AMBISOME | AMPHOTERICIN B | 1 | UNK | 0 | |||||||||||
| 124092916 | 12409291 | 9 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | UNK | 0 | |||||||||||
| 124092916 | 12409291 | 10 | C | ISODINE | POVIDONE-IODINE | 1 | UNK | 0 | |||||||||||
| 124092916 | 12409291 | 11 | C | MICAFUNGIN | MICAFUNGIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124092916 | 12409291 | 1 | Pseudomonas infection |
| 124092916 | 12409291 | 2 | Skin candida |
| 124092916 | 12409291 | 4 | Pseudomonas infection |
| 124092916 | 12409291 | 5 | Staphylococcal infection |
| 124092916 | 12409291 | 6 | Pseudomonas infection |
| 124092916 | 12409291 | 7 | Skin candida |
| 124092916 | 12409291 | 8 | Aspergillus infection |
| 124092916 | 12409291 | 9 | Skin candida |
| 124092916 | 12409291 | 11 | Skin candida |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124092916 | 12409291 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124092916 | 12409291 | Aspergillus infection | |
| 124092916 | 12409291 | Candida infection | |
| 124092916 | 12409291 | Fungal skin infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124092916 | 12409291 | 1 | 20141103 | 20141127 | 0 | |
| 124092916 | 12409291 | 2 | 20141206 | 20150105 | 0 | |
| 124092916 | 12409291 | 5 | 20141103 | 0 | ||
| 124092916 | 12409291 | 7 | 20141204 | 20141205 | 0 |